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Multiple testingy integrating genome-wide gene expression and genotype data is a promising
approach to identifying functional genetic variation, but is hampered by the large number of multiple
comparisons inherent in such studies. A novel approach to addressing multiple testing problems in genome-
wide family-based association studies is screening candidate markers using heritability or conditional power.
We apply these methods in settings in which microarray gene expression data are used as phenotypes,
screening for SNPs near the expressed genes. We perform association analyses for phenotypes using a
univariate approach. We also perform simulations on trios with large numbers of causal SNPs to determine
the optimal number of markers to use in a screen. We demonstrate that our family-based screening approach
performs well in the analysis of integrative genomic datasets and that screening using either heritability or
conditional power produces similar, though not identical, results.
© 2008 Elsevier Inc. All rights reserved.The advent of high-throughput genotyping platforms has revolu-
tionized disease gene mapping by making genome-wide association
(GWA) studies both physically and technically feasible. The typical
GWA study entails genotyping several hundreds of thousands of
genetic variants in large, well-characterized cohorts and subsequently
testing these variants for evidence of association with clinical disease
or health-related quantitative phenotypes. Initial studies resulted in
the successful mapping of a number of disease susceptibility traits,
including body mass index [1] (but see [2–5] for comments) and
susceptibility loci for age-related macular degeneration [6], Crohn’s
disease [7] and type 2 diabetes [8]. Despite these early successes and
the ever-increasing number of GWA studies being performed, a
consensus regarding the optimal statistical approach to analyzing
these large datasets remains elusive. Of particular interest is the ability
to detect signiﬁcant association when the functional variants confer
only modest individual genetic effect sizes, such as are expected in
complex diseases inwhich many genes each contribute only modestly
to the complex clinical phenotype.
Furthermore, while some adjustment for the large number of
comparisons performed is required to mitigate against overwhelming
type I error, most multiple comparison adjustment methods (such asl rights reserved.Bonferroni or false discovery rate [9]) further compromise this limited
statistical power. One promising approach to addressing the multiple
comparisons dilemma is the family-based screening algorithm
described by van Steen et al. [10], a two-stage procedure whereby all
testable SNPs are ﬁrst ranked according to their expected inﬂuence on
phenotype (measured either as SNP-speciﬁc heritability or as condi-
tional power—step 1) and then only those markers with the highest
expected effect are formally tested for genetic association (step 2). As
such, only those markers with the highest pretest probability of
demonstrating association are actually tested, thereby dramatically
reducing the number of comparisons performed (Bonferroni adjust-
ment needs to be done only for this smaller number of comparisons).
The two stages are statistically independent and are robust to the
effects of population stratiﬁcation [10], and the approach was used to
identify a genetic determinant of obesity, a ﬁnding that has subse-
quently been replicated in no fewer than six populations [1,11].
Although this family-based screening approach largely addresses
the multiple comparison issues of GWA studies, it, like all other
multiple comparison corrections, does not address the prevailing issue,
namely, that most genetic variants inﬂuencing common, complex
clinical phenotypes likely confer relatively small genetic effects,
making their identiﬁcation via direct association mapping very
difﬁcult, evenwith extremely large sample sizes. For complex diseases,
phenotypes typically are indirectly related to underlying genetics. This
Fig. 1. Average number (out of 100) of causal SNPs detected as a function of the log10
number of the top k marker in the PBAT screen, k=1,…10,000, based on 1000
simulations and using either heritability or power as the screening criterion.
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combined interaction of several (if not many) genes with multiple
environmental factors, but also because the majority of common
genetic variations inﬂuencing complex phenotypes likely exert their
function by subtly altering gene expression (regulatory variation)
rather than by radically altering the structural integrity of genes
(coding variation) [12,13].
This latter realization has prompted the development of new expe-
rimental models for the rapid identiﬁcation of regulatory variation.
One such design that is gaining increasing attention as a practical and
feasible approach is that of expression quantitative trait locus (eQTL)
mapping. First proposed by Jansen andNap [14], eQTLmapping aims to
identify regulatory polymorphism using an integrative genomics
approach whereby both genome-wide gene expression data and
genome-wide genotype data are measured in a population, and
thousands of GWA studies are performed in which each gene expres-
sion is measured as a separate quantitative trait. Using this approach,
SNPs can then be tested as potential disease-susceptibility variants.
Using SNPs is appealing because the direct genetic effects of such
variants on gene expression are likely considerably stronger (i.e.,
explain a larger proportion of the total genetic variance) than the
variants’ ultimate effects on the complex clinical trait (which result
from interactions of multiple genes and multiple environmental
factors); thus, the power to map such regulatory variation is greater
than that required to map clinical phenotypes. Moreover, if eQTL
mapping is limited to genes whose expression has been implicated in
the pathobiology of the disease in question, those variants that are
associated with both gene expression and clinical phenotype aremore
likely to be truly functional (or in linkage disequilibrium with
functional variants) than SNPs that show some association with clini-
cal phenotype but have no demonstrated regulatory impact.
Proof-of-concept eQTL studies in both animal models [e.g., 15] and
humans [16] have demonstrated the potential power of this approach.
However, because these studies involve performing repeated GWA
studies for thousands of expression traits, the number of multiple
comparisons quickly balloons. We suggest that in family-based eQTL
association studies, the family-based screening approach may be a
powerful approach to analyzing these data. Herein we explore this
potential application using both simulated and real data.
The screening algorithm
The screening algorithm is based on the method described by van
Steen et al. [10]. The algorithm is based on performing FBATs on only a
subset of the markers in the original study so that Bonferroni
adjustment needs to be done for only a small number of multiple
comparisons. The choice of the subset ofmarkers can be based on some
criterion such as heritability or conditional power (see Methods).
For this paper, association tests are performed on only the k
marker–phenotype combinations that satisfy some criterion indepen-
dent of the FBAT p values, such as heritability or conditional power [17].
Note that in this setting, the sameSNPmaybe analyzedmore thanonce
(if it is close to more than one gene), and likewise the same expressed
gene may be used more than once if it is close to several SNPs.
We consider using heritability and conditional power as criteria.
These are computed using parental markers and expected offspring
phenotype markers given the parental markers (see [18]). Because
conditional power and heritability are independent of observed
offspring genotypes conditional on the parents, the conditional power
and heritability are statistically independent of the FBAT p value.
Therefore the number of tests that need to be accounted forwhen doing
multiple comparisons is the number of marker–phenotype combina-
tions in the screen. Because there are fewer marker–phenotype
combinations surviving the screen than the original number of
combinations, it is possible to use a conservative multiple testing
correction suchasBonferroni and still obtaingenome-wide signiﬁcance.The screening algorithm can be outlined as follows:
1. Choose k, the number of marker–phenotype combinations to be in
the screen; e.g., k=10 or k=100.
2. Compute heritability or conditional power estimates for all SNP–
gene expression combinations.
3. Rank (or sort in decreasing order) SNP–gene expression combina-
tions according to either heritability or conditional power.
4. Compute FBAT p values for the top k combinations, where k was
chosen in step 1.
5. SNP–gene expression combinations are genome-wide signiﬁcant if
p≤α/k, where α is the chosen signiﬁcance level.
Results
Simulation
We simulated trios to show the power of the screening metho-
dology in a genome-wide setting and to ﬁnd optimal numbers of
marker–phenotype combinations to retain in a screen when there a
large number of causal loci, as would be expected when looking for
cis-regulatory SNPs. For each individual, we generated 1000 indepen-
dent SNPs with 10 gene expression values each, resulting in 10,000
marker–phenotype combinations. Of these, 100 of the SNPs were
chosen to be causal for one expression level, resulting in 100 of the
10,000 marker–phenotype associations being true associations. This
was done for 200 trios. The genetic effect size a is a function of the
heritability and minor allele frequency. Expression levels were drawn
from an N(aX, 1.0) distribution, where a is the effect size, and X is the
number of minor alleles at the causal SNP. Here a=0 for phenotypes
with no cis-acting SNP. This procedure was repeated 1000 times. The
number of SNPs detected based on screening the k SNP–phenotype
combinations with the highest conditional power was then recorded
for k=1,…, 10000.
We used the screening method of van Steen et al. [10] to rank
marker–phenotype combinations and pick the top k combinations,
where k=1,…, 10000, to show the power of the screening method for
every choice of k. The case of k=10, 000 corresponds to the classical
Bonferroni correction. Fig. 1 shows the power of the screening method
Fig. 2.Heritability (top) and conditional power (bottom) plotted against p values for one
of the 1000 simulated data sets using noncausal SNPs only.
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criteria. The results are very similar, with conditional power being
slightly more powerful for most k. Despite the large number of
potential tests, we found the optimal choice of k to be much smaller
than the number of tests. Using heritability as a criterion, the maxi-
mum number of true signiﬁcant associations found was with k=108
and k=110, which tied for an estimated power of 34.9%. The power
was over 34% for k=76 to k=194, and over 30% for any k between 49
and 500. Thus power decays only gradually from the optimum choice
for the number of markers in the screen. Using power as a criterion
gave very similar results, with an optimal k=124, which had an
average power of 35.1%. In this case, power was greater than 34% for
k=73 to k=204, and power was greater than 30% for any k between
48 and 505. Although sorting by power had slightly higher estimated
power for most (5609 of 10,000) choices of k, neither criterion was
uniformly more powerful.
We note that optimal choices of k are slightly higher than, but still
fairly close to the true number of causal marker–phenotype combina-
tions in the study. The Bonferroni correction method, however, detec-
ted an average of 14.8% of the causal SNPs, or approximately 42% of the
maximum power of the screening method. This is also lower power
than any choice of kN17 for either screening criterion.
The simulations also illustrate the independence (under the null
hypothesis of no association) of the FBAT p value with heritability and
conditional power. As an example, a single run of the simulation is
shown with heritability and conditional power plotted against the p
value for the 9900 marker–phenotype combinations inwhich the SNP
was noncausal, resulting in correlations of −0.005 and 0.002, respec-
tively (Fig. 2).
Data analysis
We report the candidate marker–phenotype associations that had
nominal p values below 0.05 and that survived screening the top k
marker–phenotype combinations based on both the absolute value of
heritability (k=110) and conditional power (k=124). Choices of k in
each analysis are based on the results of the simulation study.
Screening using either heritability or conditional power resulted in
12 marker–phenotype associations with pb0.05. There were 7 asso-
ciations that overlapped between the two criteria. For both methods,
onlymarkers for which therewere at least 5 informative families were
included in the screen; however, this did not affect the screening
algorithmwhen conditional power was used because only those mar-
kers with relatively large numbers of informative families were highly
powered; however, it did affect the ranks when sorting was done by
heritability.
On the basis of the simulation study, we used α=0.05/110=
0.000455 as our signiﬁcance level when sorting by heritability and
α=0.05/124=0.000403 when sorting by conditional power. There
were three genome-wide signiﬁcant associations found using either
criteria. Two of the genome-wide signiﬁcant associations were for two
SNPs (rs178814 and rs178815) located 1226 bp apart that were asso-
ciated with the same gene (Contig47134 RC) (p=1.39×10−5 and
p=1.36×10−5, respectively). These associations were both detected
using either heritability or conditional power as the screeningmethod.
Using heritability, a signiﬁcant association between rs2172962 and
Contig45657 was found (p=4.46×10−4). Screening by conditional
power did not detect this combination, but did result in one signiﬁcant
association not detected using heritability: rs925197 and Contig20565
RC (p=8.28×10−5). Thus each screening criterion was able to ﬁnd a
genome-wide signiﬁcant association not detected by the other
criterion. There was substantial overlap in the SNP–phenotype
combinations detected in the two types of screening, with seven
associations (including the two that were genome-wide signiﬁcant)
detected under both screening criteria (Tables 1 and 2). To compare
gene expression for genes that survived the screen versus those thatdid not, we averaged expression levels across all parents (to avoid the
nonindependence of children) for each gene. Using the top 118 unique-
ly occurring genes when sorting by power (6 of the 124 top genes
occurred twice in the screen), these genes had similarmeans,medians,
ranges, and variances in terms of expression (pN0.05 in each case).
Although these measures did not show dramatic differences, those
genes that survived the screen tended to havemore SNPswithin 1.0Mb
(p=4.9×10−9), with an average of 3.67 SNPs, compared to an average of
40227/14219=2.83 SNPs per gene for the entire dataset (Table 3).
Discussion
Heritability versus conditional power
An open question in using screening methodology is whether it is
better to screen based on heritability or on power. In particular,
heritability would seem to be a promising criterion because the
phenotypes can be much more highly heritable than is typical in
genetic association studies. Also, the CEPH dataset used has a small
Table 1
Marker–phenotype combinations within the top 100 heritability values where the association had FBAT p valuesb 0.05
Marker Minor allele
freqency
Gene Chrom Distance Informative
families
FBAT p value Conditional
power
Heritability Rank In Table 2?
rs2172962 0.367 Contig45657 1 40022 7 0.000446⁎ 0.238 0.535 8 N
rs178815 0.482 Contig47134 RC 17 212582 9 0.0000136⁎ 0.743 0.514 10 Y
rs178814 0.482 Contig47134 RC 17 213808 9 0.0000139⁎ 0.732 0.510 11 Y
rs1411875 0.396 NM 001081 10 338648 8 0.003438 0.712 0.473 23 Y
rs734910 0.481 Contig28617 RC 19 602979 9 0.019150 0.041 0.457 33 N
rs940287 0.294 NM 007203 9 145148 10 0.021949 0.644 0.437 44 Y
rs2143544 0.430 Contig31391 RC 20 164659 9 0.025907 0.291 0.429 49 N
rs1015416 0.202 NM 005024 18 13362 11 0.002059 0.958 0.428 50 Y
rs2008734 0.489 NM 016055 11 132030 10 0.036777 0.618 0.403 73 Y
rs740951 0.295 Contig35752 7 268660 6 0.002635 0.491 0.395 79 N
rs740672 0.253 AB033102 4 67855 11 0.007647 0.723 0.388 84 Y
rs584109 0.428 NM 015368 11 97619 11 0.001409 0.536 0.384 92 N
Rank refers to the heritability within the top 110. Distance refers to the minimum distance of the SNP to either end of the gene.
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sorting by power tended to favor marker–phenotype combinations that
hadhighernumbersof informative families thandid sortingbyheritability
(Tables 1 and 2). On the basis of this study, however, we ﬁnd the
performance of the twomethods to be very similar in the number of SNPs
detected, both in the simulation study and using real data. Because more
SNPs can be detected using both approaches than using one alone, we
cannot recommend using one criterion exclusively. Combining criteria a
possibility. For example, a method for combining objective criteria for
ranking genes in expression studies has been developed [19].
Computational issues
The amount of computation time is linear in the number of marker–
phenotype combinations. We note that this problem is highly parallel,
with each of the 40,227 associations being computed independently. For
this data set, the total computation timewasunder24h runningPBAT [20]
on 20processors inparallel on a linux cluster. Thus, if parallel processing is
available, an entire genome-wide dataset with this type of data can be
analyzed quickly by using the strategy of analyzing SNP–phenotype
associationswhere SNPs arewithin somewindowof the expressed genes.
The method could also be used for extended pedigrees by taking
advantage of parallel computing, although computation time can increase
signiﬁcantly compared to the time for nuclear families for some
combinations of missing parental and grandparental markers.
Conclusions
In the analysis presented, we limited the number of associations by
only considering SNPs on the same chromosome as the gene tran-
scripts thatwerewithin1.0Mbof thegene.Although thismethod isusefulTable 2
Marker–phenotype combinations within the top 100 conditional power values where the a
Marker Minor allele
frequency
Gene Chrom Distance Inform
familie
rs1015416 0.202 NM 005024 18 13362 11
rs1997034 0.201 Contig27827 RC 1 600645 12
rs178815 0.482 Contig47134 RC 17 212582 9
rs178814 0.482 Contig47134 RC 17 213808 9
rs740672 0.253 AB033102 4 67855 11
rs2009989 0.157 NM 005024 18 30768 10
rs586853 0.223 Contig16931 5 394577 12
rs1411875 0.396 NM 001081 10 338648 8
rs925197 0.216 Contig20565 RC 5 17139 8
rs940287 0.294 NM 007203 9 145148 10
rs2008734 0.489 NM 016055 11 132030 10
rs1968867 0.135 AL109691 15 744682 10
Rank refers to conditional power within the top 124.for looking for possible cis-acting SNPs, the method could be extended to
look for trans-acting SNPs by considering markers further from the gene
transcripts or even on different chromosomes. Thiswould have the cost of
increasing the number of conditional power and heritability estimates to
be computed, but this could be accomplished with parallel computing. A
strategy for reducing the number of associations to be computed is to use
principal components (FBAT-PC [21]), in which multiple phenotypes are
analyzed for each SNP by ﬁnding the linear combination of phenotypes
that maximizes heritability (the ﬁrst principal component). This linear
combination is then analyzed as a single phenotype, thus greatly reducing
the total number of phenotypes (and therefore SNP-phenotype combina-
tions) to be analyzed. Although generally the large number of gene
expression values increases the severity of themultiple testing problem in
association studies, the methods of this paper demonstrate the feasibility
of incorporating integrative genomics data in GWA studies in a family-
based setting.
Methods
We used data from 15 CEPH families (IDs 1334, 1340, 1345, 1346,
1349, 1350, 1358, 1362, 1375, 1377, 1408, 1418, 1421, 1424, 1477) also
used in Monks et al. [22]. To use only nuclear families we did not
include grandparents in the analysis. This resulted in 142 indivi-
duals, 112 of whom were offspring. Gene expression data were
available for 24 of the 30 parents and 91 of the offspring. Data were
available for 23,880 expressed genes and 2322 genotyped SNPs on
the 22 autosomal chromosomes. We performed association analysis
on the 40,227 SNP–gene expression combinations where the SNP
was within 1.0 Mb of one end of the gene. This resulted in 2279 SNPs
and 14219 expressed genes, with an average of 17.65 genes per SNP
(Table 3).ssociation had FBAT p -valuesb 0.05
ative
s
FBAT p value Conditional
power
Heritability Rank In Table 1?
0.002059 0.958 0.428 2 Y
0.030215 0.786 0.306 38 N
0.0000136⁎ 0.743 0.514 43 Y
0.0000139⁎ 0.732 0.510 46 Y
0.007647 0.723 0.388 49 Y
0.003973 0.720 0.257 51 N
0.005587 0.712 0.290 54 N
0.003438 0.712 0.473 55 Y
0.0000828⁎ 0.710 0.268 57 N
0.021849 0.642 0.309 84 Y
0.036777 0.618 0.403 104 Y
0.006775 0.607 0.205 111 N
Table 3
Number of Marker–phenotype combinations for the CEPH dataset within a given
distance from the gene
Distance Marker–phenotype
combination
Number
of SNPs
Number of
expressed
genes
Genes
per SNP
50 kb 2,241 1090 1,495 2.06
100 kb 4,181 1462 2,388 2.86
500 kb 19,913 2122 8,757 9.38
1 Mb 40,227 2279 14,219 17.65
2 Mb 79,009 2314 19,352 34.14
The same SNP may occur in more than one combination, and similarly, the same
expressed gene may occur in more than one combination.
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markers and phenotypes where the SNP was within 1.0 Mb of either
end of the expressed gene, resulting in 40,227 marker–phenotype
combinations. See Table 3 for the number of combinations as a
function of distance from genes. Because of computational difﬁculties
when there were missing markers in both parents and grandparents,
we limited our analysis to nuclear families obtained by only
considering parents and offspring, i.e., by excluding the grandparental
generation. Univariate family-based association analyses were then
performed on the marker–phenotype combinations. An additive
genetic model was used in all analyses. The dataset was then sorted
using two different criteria: heritability and conditional power.
Heritability is deﬁned as the proportion of phenotypic variability
that can be explainedbygenotypic variability [23].Weuse SNP-speciﬁc
heritability. The conditional power is computed from the conditional
mean model using the methods in [24]. In the model, the genotype of
the offspring is a randomvariable conditioned on the genotypes of the
parents, and the phenotype Yij (e.g., the gene expression level)
depends on the expected conditional offspring genotypes:
E Yij
  ¼ aE Xijjparental genotypes
 þ bZij: ð1Þ
Here observed genotypes of the jth offspring in the ith family, Xij, have
been replaced by their expected values given the parental values.
Under an additive inheritancemodel, Xij is the number of minor alleles
for the individual at a locus. If parental values are missing, sufﬁcient
statistics for the parental markers can be used instead [25]. The term
Zij allows for covariate adjustment.
In each analysis, the top 100 combinations among the 40,227 were
retained for statistical testing, i.e., computing FBAT p values when
there is a continuous phenotype, the gene expression value. The FBAT
test statistic is
FBAT ¼ ∑
ij
Yij−μ
 
Xij−E Xij
  
∑ijY2ijVar Xij
  ; ð2Þ
where Yij represents the phenotype (e.g., gene expression) of the jth
offspring in family i. Because an additive genetic model is being used,
Xij denotes the number of minor alleles for the jth offspring in the ith
family. The parameter μ is an offset parameter estimated from the data
[18]. The FBAT statistic has an approximate standard normal
distribution under the null hypothesis of no linkage and no
association. For an overview of generalizations of the FBAT statistic,
see Laird and Lange [17].
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